LIVN News & Events

ivaNova (LIVN) announced that Stefano Folli will join the Company as incoming President, Cardiopulmonary effective June 1, succeeding Franco Poletti, who will retire on July 31. Folli will partner closely with Poletti over the coming months to ensure a seamless leadership transition before assuming full responsibility for the business on August 1. Folli will join the LivaNova Executive Leadership Team and report to CEO Vladimir Makatsaria. In this role, Folli will oversee the strategic growth of the nearly $800-million business, which includes a complete range of Cardiopulmonary disposables and equipment, including the Essenz Perfusion System. Most recently, Folli served as Executive Vice President, Global President Ambulatory Monitoring & Diagnostics at Philips (PHG).

LivaNova (LIVN) announced that Stefano Folli will join the Company as incoming President, Cardiopulmonary effective June 1, succeeding Franco Poletti, who will retire on July 31. Folli will partner closely with Poletti over the coming months to ensure a seamless leadership transition before assuming full responsibility for the business on August 1. Folli will join the LivaNova Executive Leadership Team and report to CEO Vladimir Makatsaria. In this role, Folli will oversee the strategic growth of the nearly $800-million business, which includes a complete range of Cardiopulmonary disposables and equipment, including the Essenz Perfusion System. Most recently, Folli served as Executive Vice President, Global President Ambulatory Monitoring & Diagnostics at Philips (PHG).